Abstract 167: Noninvasive MRI Measurement of Cerebrovascular Reactivity Enables Evaluation of Surgical Revascularization Response in Moyamoya
Introduction: Frequent dissociation between clinical severity and angiographic grading of moyamoya supports a role for alternative tissue-level hemodynamic measures. Here, angiography is complemented with noninvasive MRI measurements of parenchymal impairment to assess changes in cerebrovascular reactivity (CVR) after extracranial-intracranial bypass in moyamoya. Hypothesis: CVR is regionally impaired pre-operatively, yet increases after surgery. This can be visualized noninvasively by assessing blood oxygenation level-dependent (BOLD) MRI changes with safe, mildly hypercarbic gas. Methods: Using a block MRI paradigm, carbogen (5% CO 2 ; 95% O 2 3 min) was interleaved with atmospheric air (<1% CO 2 ; 3 min) administration during BOLD MRI in intracranial stenosis patients (n=70), a subset of which (n=9; age=35.7+/-10.8; 7F/2M) underwent indirect (n=8) or direct (n=1) revascularization for moyamoya. Five patients had both pre-operative and post-operative hemodynamic imaging, with post-operative scans performed after 7.3+/-4.1 months. CVR, calculated as a z-statistic in response to hypercarbia vs. atmospheric air, was compared (two-tailed t-test) for each patient between the two time points to correlate CVR changes with surgery. Results: Fig. 1 shows BOLD MRI on a patient scanned before and 2 years after right-sided indirect bypass, with significant (t=79.29, p<0.01) right-sided hemodynamic improvement. Cohort analyses of patients with pre/post-operative scans revealed significant interhemispheric CVR differences prior to surgery (t=3.48, p<0.01), which resolved after bypass (t=0.88, p=0.20). Additionally, CVR increased significantly in the operative hemisphere (t=4.50, p<0.01). Conclusions: CVR-weighted hemodynamic MRI can be implemented into routine clinical protocols, corresponds well with revascularization response, and has potential as a noninvasive complement to angiography for serial monitoring of moyamoya patients.